Hyperinsulinemic Euglycemic Insulin Sensitivity Clamp

About

Insulin resistance, which may be defined as an impaired ability of insulin to modulate metabolism in target tissues, is a major therapeutic target in type 2 diabetes. In particular, accurate measurement of insulin action is necessary for the development of novel insulin-sensitizing drugs. The hyperinsulinemic euglycemic clamp, used primarily to assess insulin-mediated glucose disposal, is widely regarded as the reference method. ProSciento offers expertise in the measurement of insulin sensitivity using automated two-step hyperinsulinemic euglycemic clamp technology. This approach offers greater accuracy and less variability than manual clamps that are more operator-dependent.

Hyperinsulinemic Euglycemic Insulin Sensitivity Clamp thumbnail

Recommended Materials

Hyperinsulinemic Euglycemic Insulin Sensitivity Clamp thumbnail

Posters

Glucose Clamp Quality Parameters Among Study Populations

Hyperinsulinemic Euglycemic Insulin Sensitivity Clamp thumbnail

Articles

Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline

Hyperinsulinemic Euglycemic Insulin Sensitivity Clamp thumbnail

Fact Sheets

Introduction to Glucose Clamps: Automated Versus Manual Techniques

Related Solutions

Automated Glucose Clamp Techniques thumbnail

Specialized Methods

Diabetes thumbnail

Our Metabolic Focus